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Few people would doubt that espe-
cial feeding procedures are an essen-
tial part of the therapeutic arsenal
against Crohn’s disease and ulcerative
colitis. It must be recognized that
many patients afflicted by these con-
ditions either suffer from benign and
self-limited modalities, or else respond
favorably to medical or surgical treat-
ment. In circumstances where acute
episodes can be effectively curtailed
and remissions are long, extending for
years or decades, nutritional status
tends to be comparatively  well pre-
served and  complex nutritional inter-
ventions are seldom needed.
For patients who are not so lucky,
notably those exhibiting aggressive
Crohn’s disease, a long and miserable
life is traditionally anticipated. Ex-
tended periods of exacerbation requir-
ing or not hospitalization, frequent
surgical maneuvers potentially result-
ing in visceral mutilation and tempo-
rary or permanent ostomy, anorectal
infectious and inflammatory troubles,
complications and comorbidities in
distant organs and systems,  and con-
sumption of numerous and sometimes
poorly tolerated drugs are a constant
threat.
Anemia, hypoproteinemia and ero-
sion of body energy and protein com-
partments are hard to avoid in such a
context, further interfering with the
patient’s ability to work, study, play,
maintain social and family relations,
and enjoy a healthy and rewarding
life. Children pay an even higher price,
not only because of the intrinsic psy-
chological fragility and vulnerability
of these organisms, but also because
secondary malnutrition often results in
growth arrest and stunting.
It is no coincidence that histori-
cally, many of the first candidates for
home artificial nutrition suffered from
digestive sequelae of Crohn’s disease,
and in some parts of the world they still
represent one of the largest groups de-
pendent on home care and long-term
nutritional support1.
Among the first 50 surgical pa-
tients submitted to parenteral feeding
in Hospital das Clinicas between 1971
and 19752,  mostly displaying
gastrointestinal fistulas and abscesses,
Crohn’s disease was already quite
prominent. Two particularly severe
cases of high-output fistulas required
many months of  alimentation via a
central venous catheter before dis-
charge. One of them was subsequently
treated by home oral support and daily
dressing changes during  one year, un-
til all  fistulas healed, and the other re-
quired hospital admissions and  addi-
tional periods of intravenous feeding
during the next five years, because of
persistent fever, diarrhea and abscesses.
Long  term follow-up illustrates the
vagaries of prognosis in inflammatory
bowel disease. The first patient had 12
years of remission, only to succumb to
colon cancer, whereas the other still
suffers from occasional bouts of
diarrhea, but is alive and well nearly
30 years after initial diagnosis.
The fundamental step towards im-
proving the outlook of any clinical
condition is elucidating its patho-
physiology, and the sad truth is that to
this date nobody has pinpointed the
exact mechanism that triggers bowel
damage in these chronic illnesses. The
immune system is certainly involved,
bacterial theories come and go every
couple of decades, genetic influences
cannot be denied, psychological fac-
tors have been strongly defended in
the past, and a variety of other hy-
potheses can be found in the literature,
but without single etiologic agents

REV. HOSP. CLÍN. FAC. MED. S. PAULO 57(4):129-130, 2002 JULY-AUGUST
that are amenable to prophylaxis or
neutralization3.
In spite of these shortcomings, sur-
gical options have become less muti-
lating and more effective in recent
years, new and powerful drugs have
been introduced in the market, and last
but not least, nutritional status has
been markedly improved by intelligent
application of  oral, enteral and
parenteral prescriptions. Even children
with growth retardation often react
with catch-up responses and enjoy the
opportunity  to achieve more accept-
able adult height4.
During many  years most of the dis-
cussions around nutritional care fo-
cused on the degree of hypermetabo-
lism that is associated with inflamma-
tory bowel disease, and as a corollary,
on how much energy and protein one
was supposed to administer in that con-
text. It is unquestionable that some-
body acutely affected by  Crohn’s ab-
scesses and fistulas  or by toxic mega-
colon secondary to ulcerative colitis
can be markedly hypermetabolic , and
may therefore require additional calo-
ries and notably a high  nitrogen allow-
ance in order to achieve nitrogen bal-
ance. The same is generally true in the
immediate postoperative period, for in-
dividuals undergoing major  operations
such as total colectomy or extensive
small bowel resections, although exag-
gerated intakes above 40 kcal/kg/day
are avoided nowadays.
Whereas basic indications and
modalities of especialized feeding for
Crohn’s disease, ulcerative colitis and
their complications are quite obvious
in the clinical routine, and present no
great challenge to  experienced medi-
cal teams, more transcendent doubts
have been around for a number of
years: 1) Do parenteral and enteral nu-
trition promote remission, and if yes,
are the rates comparable to those
achieved by corticosteroids and other
anti-inflammatory drugs? 2) Is the ben-
eficial impact of nutritional support
linked to bowel rest, and if yes, which
diet and route of administration should
be preferred? 3) What is the role of
omega-6, omega-3, medium- chain and
short-chain fatty acids in the response
to medical feedings?  Is long-term sup-
plementation or substitution of lipids
desirable, after hospital discharge? 4)
Are immune-stimulating preparations
including  glutamine and antioxidants
better than standard formulations in
this context?
These are meaningful details for
chronic ailments that may accompany
the patient during all his life, and al-
though wrong dietetic options are not
fraught with the same dangers as inap-
propriate drug regimens or unfortunate
surgical procedures, they still involve
potential deterioration of nutritional
status and quality of life (or lack of
improvement thereof), and not incon-
siderable expense.
Not all of the nutritional issues
have been squarely addressed in the
article that follows5, which adopted a
somewhat diferent approach, and in
fact many ongoing investigations are
still aiming to find the correct answers
to  some of these complex and relevant
questions. In any case, the extensive
and up-to-date review will shed pre-
cious light on the advantages and dis-
advantages of available dietetic alter-
natives. In this sense, it should con-
tribute both to  better understanding
of the principles that govern nutri-
tional assessment and therapeutic as-
sistance in inflammatory bowel dis-
ease, and to  safer and more successful
results in the practical management of
these subjects.
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